Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome.

Kamal, Amany M; Nabih, Nermeen A; Elleboudy, Nooran S; Radwan, Sara M

Kamal, Amany M; Nabih, Nermeen A; Elleboudy, Nooran S; Radwan, Sara M.

Afiliação

Kamal AM; Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
Nabih NA; Department of Internal Medicine, Clinical Hematology and Bone Marrow Transplantation Unit, Faculty of Medicine, Ain Shams University, Cairo 11591, Egypt.
Elleboudy NS; Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
Radwan SM; Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.

Oncol Lett ; 21(4): 325, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33692857

Palavras-chave

T lymphocytes; T-cell immunoglobulin and mucin domain 3; acute myeloid leukemia; gene expression; induction chemotherapy; prognosis; reverse transcription-quantitative PCR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google